Similar Items: Mass spectrometry‐based mitochondrial proteomics for cancer biomarker discovery
- Quantitative tandem mass tag-based serum proteomics for longitudinal biomarker monitoring in Duchenne muscular dystrophy
- Quantitative enrichment of amyloid precursors refines mass spectrometry-based amyloidosis diagnosis
- Noninvasive early detection and grading of pneumoconiosis via plasma proteomics and machine learning: PRSS3 as a potential biomarker
- Integrating mass spectrometry and systems biology for the modernization of natural medicines: From deciphering chemical complexity to holistic efficacy assessment
- Protein modification systems as cancer biomarkers and therapeutic targets
- Modulation of the immunogenic landscape in colorectal cancer by mitochondrial methylation-controlled J protein